Novel Anticancer Strategies

doi:10.3390/books978-3-0365-7030-3

Reprint

Download Flyer

Novel Anticancer Strategies

Edited by

March 2023

396 pages

ISBN978-3-0365-7031-0 (Hardback)
ISBN978-3-0365-7030-3 (PDF)

https://doi.org/10.3390/books978-3-0365-7030-3

Free download (PDF)

This book is a reprint of the Special Issue Novel Anticancer Strategies that was published in

Biology & Life Sciences

Chemistry & Materials Science

Medicine & Pharmacology

Summary

Novel Anticancer Strategies reviews important findings and updates within the cancer therapy field, of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original and review articles devoted to key areas of major progress and expectations. Key features: Nanoparticle-based drug delivery in cancer therapy; Extracellular vesicles for anticancer drug delivery; Peptide-based drug conjugates; Cancer stem cells as a valuable target to eradicate tumor relapse; Spheroids in preclinical model for cancer research; and cancer immunotherapy.

Format

Hardback

License

Keywords

tumor-homing extracellular vesicles; pH-sensitive extracellular vesicles; doxorubicin; tumor therapy; pancreatic cancer; targeted tumor therapy; homing peptide; antitumor peptide conjugates; daunomycin; oxime linkage; combinatorial immunotherapy; cytotoxics; biomarkers; precision medicine; immunotherapy; anti-PD-L1; ionizing irradiation; pharmacokinetics; tumor-immune interaction; global sensitivity; immuno-oncology; mathematical modeling; glycol chitosan nanoparticle; high-intensity focused ultrasound; deep tumor penetration; dense ECM; cancer treatment; prostate cancer; gastrin-releasing peptide receptor; RM26; albumin-binding domain; targeted therapy; gastrin-releasing peptide receptors (GRPR) antagonist; cervical cancer; tetraarsenic hexoxide; patient-derived xenograft; autophagy; cisplatin; fenbendazole; micelle solubilization; pharmacokinetics; Soluplus^® polymeric micelles; toxicity test; sonoporation; microbubbles; ultrasound; intracellular signaling; phosphorylation; ultrasound contrast agents; drug delivery; cellular stress; pancreatic cancer; tumour microenvironment; cancer stem cells; extracellular vesicles; drug delivery systems; liposomes; immunoliposomes; antisense oligonucleotides; prostate cancer; 3D cultures; tumor microenvironment; tumor spheroids; efficacy analysis; drug resistance; cancer therapy; glioblastoma; receptor tyrosine kinases; epidermal growth factor receptor; small molecule inhibitors; nanoformulations; breast cancer; micelles; dendrimers; anticancer drugs; drug delivery; doxorubicin; platinum drug; methotrexate; lung metastasis; liver metastasis; cancer stem cells; cancer treatments and progression biomarkers; mesoporous silica nanoparticles; controlled release; drug delivery systems; anticancer natural prodrugs; natural products; cancer targeting; nanoformulations/nanomedicine applications; n/a